Assembly Bill A6425

2023-2024 Legislative Session

Relates to requiring insurance coverage for epinephrine auto-injectors

download bill text pdf

Sponsored By

Current Bill Status Via S7114 - Passed Assembly


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

Bill Amendments

co-Sponsors

2023-A6425 - Details

Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L

2023-A6425 - Summary

Requires health insurance plans to provide coverage for epinephrine auto-injector devices; caps the cost to an insured at $100 per year.

2023-A6425 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6425
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               April 6, 2023
                                ___________
 
 Introduced  by  M.  of  A.  O'DONNELL  --  read once and referred to the
   Committee on Insurance
 
 AN ACT to amend the insurance  law,  in  relation  to  requiring  health
   insurance  plans  to  provide  coverage  for epinephrine auto-injector
   devices
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 39 to read as follows:
   (39) EVERY INSURER ISSUING A POLICY OF ACCIDENT AND  HEALTH  INSURANCE
 DELIVERED  OR  ISSUED  FOR  DELIVERY  IN THIS STATE WHICH PROVIDES MAJOR
 MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE  SHALL  INCLUDE  COVERAGE
 FOR  TWO  MEDICALLY  NECESSARY EPINEPHRINE AUTO-INJECTOR DEVICES FOR THE
 EMERGENCY TREATMENT OF LIFE-THREATENING ALLERGIC REACTIONS.  SUCH COVER-
 AGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND  COINSURANCE    AS  MAY  BE
 DEEMED  APPROPRIATE  BY  THE  SUPERINTENDENT  AND AS ARE CONSISTENT WITH
 THOSE  ESTABLISHED FOR OTHER BENEFITS WITHIN A  GIVEN  POLICY;  PROVIDED
 HOWEVER,  THE TOTAL AMOUNT THAT A COVERED PERSON IS REQUIRED TO PAY OUT-
 OF-POCKET FOR SUCH DEVICES SHALL BE CAPPED AT AN AMOUNT  NOT  TO  EXCEED
 ONE  HUNDRED  DOLLARS ANNUALLY REGARDLESS   OF THE INSURED'S DEDUCTIBLE,
 COPAYMENT, COINSURANCE OR ANY OTHER COST-SHARING  REQUIREMENT.  FOR  THE
 PURPOSES  OF  THIS  PARAGRAPH,  "EPINEPHRINE AUTO-INJECTOR DEVICE" SHALL
 HAVE THE SAME MEANING AS PROVIDED IN PARAGRAPH (B) OF SUBDIVISION ONE OF
 SECTION THREE THOUSAND-C OF THE PUBLIC HEALTH LAW.
   § 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 23 to read as follows:
   (23) EVERY GROUP OR BLANKET POLICY OF ACCIDENT  AND  HEALTH  INSURANCE
 DELIVERED  OR  ISSUED  FOR DELIVERY IN THIS STATE WHICH PROVIDES MEDICAL
 COVERAGE THAT INCLUDES COVERAGE FOR PHYSICIAN SERVICES IN A  PHYSICIAN'S
 OFFICE  AND EVERY POLICY WHICH PROVIDES MAJOR MEDICAL OR SIMILAR COMPRE-
 HENSIVE-TYPE  COVERAGE SHALL PROVIDE COVERAGE FOR TWO  MEDICALLY  NECES-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10597-01-3
              

co-Sponsors

2023-A6425A (ACTIVE) - Details

Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L

2023-A6425A (ACTIVE) - Summary

Requires health insurance plans to provide coverage for epinephrine auto-injector devices; caps the cost to an insured at $100 per year.

2023-A6425A (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  6425--A
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               April 6, 2023
                                ___________
 
 Introduced  by  M.  of  A.  O'DONNELL, PAULIN, LUNSFORD, LAVINE, WEPRIN,
   SIMON, BURDICK, DAVILA, STERN,  SILLITTI,  SIMONE,  SHIMSKY,  DICKENS,
   DeSTEFANO,  LEMONDES,  McDONOUGH,  JACOBSON,  STECK  --  read once and
   referred to the Committee on Insurance -- recommitted to the Committee
   on Insurance in accordance with Assembly Rule 3, sec. 2  --  committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN  ACT  to  amend  the  insurance  law, in relation to requiring health
   insurance plans to  provide  coverage  for  epinephrine  auto-injector
   devices
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
 amended by adding a new paragraph 39 to read as follows:
   (39)  (A) EVERY INSURER ISSUING A POLICY OF ACCIDENT AND HEALTH INSUR-
 ANCE DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE WHICH PROVIDES MAJOR
 MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE  SHALL  INCLUDE  COVERAGE
 FOR,  AT  A  MINIMUM,  TWO MEDICALLY NECESSARY EPINEPHRINE AUTO-INJECTOR
 DEVICES  FOR  THE  EMERGENCY  TREATMENT  OF  LIFE-THREATENING   ALLERGIC
 REACTIONS.  SUCH COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND COIN-
 SURANCE    AS MAY BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS ARE
 CONSISTENT WITH THOSE   ESTABLISHED FOR OTHER BENEFITS  WITHIN  A  GIVEN
 POLICY;  PROVIDED    HOWEVER,  THE TOTAL AMOUNT THAT A COVERED PERSON IS
 REQUIRED TO PAY OUT-OF-POCKET FOR SUCH DEVICES SHALL  BE  CAPPED  AT  AN
 AMOUNT  NOT  TO  EXCEED  ONE HUNDRED DOLLARS ANNUALLY REGARDLESS  OF THE
 INSURED'S DEDUCTIBLE, COPAYMENT, COINSURANCE OR ANY  OTHER  COST-SHARING
 REQUIREMENT.  IF UNDER  FEDERAL  LAW,  APPLICATION  OF  THIS REQUIREMENT
 WOULD    RESULT  IN  HEALTH SAVINGS ACCOUNT INELIGIBILITY UNDER  26  USC
 223,   THIS REQUIREMENT   SHALL     APPLY     FOR     HEALTH     SAVINGS
 ACCOUNT-QUALIFIED  HIGH  DEDUCTIBLE  HEALTH  PLANS  WITH  RESPECT TO THE
 DEDUCTIBLE OF SUCH A PLAN AFTER THE ENROLLEE HAS SATISFIED  THE  MINIMUM
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10597-02-4
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.